WHO secures 20% funding increase amid US shortfall
Despite the boost to contributions, the WHO has downsized its 2026-2027 budget by over $1bn due to financial constraints.
Investment
Sanofi commits ‘at least $20bn’ to US manufacturing through 2030
VC firm Vivo Capital outlays $740m for biotech investment
European biotechs must understand US culture while seeking funding
Investors insist halted biotech IPOs will return in 2025
Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil
ABPI calls on UK Government to resolve “VPAG crisis”
Saving shelved ultra-rare therapies through unorthodox funding
